News

AI in Clinical Trials - Global Strategic Business Report 2026: Secure Share of a US$4.1 Billion Market by 2032 with IQVIA, Microsoft, Tempus AI, and Saama

Yahoo

Company Logo Dublin, Nov. 18, 2026 (GLOBE NEWSWIRE) -- "AI in Clinical Trials - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global artificial intelligence (AI) in clinical trials market was valued at US$1.6 billion in 2025 and is projected to reach US$4.1 billion by 2032, expanding at a compound annual growth rate (CAGR) of 14% during the forecast period. Market growth is being supported by rising drug development costs, increasingly complex clinical protocols, demand for personalized therapies, and the pharmaceutical industry's focus on accelerating time to market.

Read the full Veytics brief

We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.